Annual EBITDA
-$133.64 M
+$60.05 M+31.00%
December 31, 2023
Summary
- As of February 26, 2025, FBIO annual EBITDA is -$133.64 million, with the most recent change of +$60.05 million (+31.00%) on December 31, 2023.
- During the last 3 years, FBIO annual EBITDA has fallen by -$45.82 million (-52.18%).
- FBIO annual EBITDA is now -1282.90% below its all-time high of -$9.66 million, reached on December 31, 2010.
Performance
FBIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$21.07 M
+$5.08 M+19.42%
September 30, 2024
Summary
- As of February 26, 2025, FBIO quarterly EBITDA is -$21.07 million, with the most recent change of +$5.08 million (+19.42%) on September 30, 2024.
- Over the past year, FBIO quarterly EBITDA has dropped by -$15.11 million (-253.81%).
- FBIO quarterly EBITDA is now -911.82% below its all-time high of -$2.08 million, reached on September 30, 2010.
Performance
FBIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$108.43 M
-$15.11 M-16.19%
September 30, 2024
Summary
- As of February 26, 2025, FBIO TTM EBITDA is -$108.43 million, with the most recent change of -$15.11 million (-16.19%) on September 30, 2024.
- Over the past year, FBIO TTM EBITDA has increased by +$51.22 million (+32.08%).
- FBIO TTM EBITDA is now -5107.88% below its all-time high of -$2.08 million, reached on September 30, 2010.
Performance
FBIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
FBIO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.0% | -253.8% | +32.1% |
| 3 y3 years | -52.2% | +66.4% | +25.8% |
| 5 y5 years | -12.9% | +17.6% | -5.7% |
FBIO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.0% | -253.8% | +66.4% | -16.2% | +47.1% |
| 5 y | 5-year | -52.2% | +31.0% | -253.8% | +66.4% | -26.5% | +47.1% |
| alltime | all time | -1282.9% | +31.0% | -911.8% | +66.4% | -5107.9% | +47.1% |
Fortress Biotech EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$21.07 M(-19.4%) | -$108.43 M(+16.2%) |
| Jun 2024 | - | -$26.14 M(-27.1%) | -$93.32 M(-22.0%) |
| Mar 2024 | - | -$35.84 M(+41.2%) | -$119.57 M(-10.5%) |
| Dec 2023 | -$133.64 M(-31.0%) | -$25.38 M(+326.3%) | -$133.65 M(-16.3%) |
| Sep 2023 | - | -$5.95 M(-88.6%) | -$159.65 M(-20.4%) |
| Jun 2023 | - | -$52.40 M(+5.0%) | -$200.68 M(+1.2%) |
| Mar 2023 | - | -$49.91 M(-2.9%) | -$198.28 M(+2.4%) |
| Dec 2022 | -$193.69 M(+32.5%) | -$51.38 M(+9.4%) | -$193.69 M(-5.5%) |
| Sep 2022 | - | -$46.99 M(-6.0%) | -$205.04 M(+3.3%) |
| Jun 2022 | - | -$50.00 M(+10.3%) | -$198.45 M(+17.5%) |
| Mar 2022 | - | -$45.32 M(-27.8%) | -$168.91 M(+15.6%) |
| Dec 2021 | -$146.17 M(+66.4%) | -$62.73 M(+55.3%) | -$146.17 M(+45.4%) |
| Sep 2021 | - | -$40.40 M(+97.5%) | -$100.54 M(+17.3%) |
| Jun 2021 | - | -$20.45 M(-9.4%) | -$85.72 M(-4.8%) |
| Mar 2021 | - | -$22.58 M(+32.0%) | -$90.00 M(+2.5%) |
| Dec 2020 | -$87.82 M(-0.7%) | -$17.10 M(-33.1%) | -$87.82 M(-14.4%) |
| Sep 2020 | - | -$25.58 M(+3.4%) | -$102.62 M(+5.1%) |
| Jun 2020 | - | -$24.73 M(+21.2%) | -$97.61 M(+1.5%) |
| Mar 2020 | - | -$20.41 M(-36.0%) | -$96.19 M(+8.0%) |
| Dec 2019 | -$88.48 M(-25.3%) | -$31.90 M(+55.1%) | -$89.10 M(+0.8%) |
| Sep 2019 | - | -$20.57 M(-11.8%) | -$88.41 M(-7.8%) |
| Jun 2019 | - | -$23.32 M(+75.1%) | -$95.85 M(-2.5%) |
| Mar 2019 | - | -$13.31 M(-57.3%) | -$98.30 M(-17.4%) |
| Dec 2018 | -$118.40 M(+33.7%) | -$31.21 M(+11.4%) | -$119.06 M(+9.1%) |
| Sep 2018 | - | -$28.02 M(+8.7%) | -$109.16 M(-3.7%) |
| Jun 2018 | - | -$25.77 M(-24.4%) | -$113.40 M(+4.6%) |
| Mar 2018 | - | -$34.07 M(+59.9%) | -$108.39 M(+23.7%) |
| Dec 2017 | -$88.57 M | -$21.31 M(-34.0%) | -$87.62 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$32.26 M(+55.4%) | -$84.93 M(+23.6%) |
| Jun 2017 | - | -$20.75 M(+56.1%) | -$68.74 M(+7.8%) |
| Mar 2017 | - | -$13.30 M(-28.5%) | -$63.75 M(-4.6%) |
| Dec 2016 | -$66.47 M(+26.9%) | -$18.61 M(+15.8%) | -$66.84 M(+6.4%) |
| Sep 2016 | - | -$16.07 M(+1.9%) | -$62.84 M(-5.2%) |
| Jun 2016 | - | -$15.77 M(-3.8%) | -$66.27 M(+17.2%) |
| Mar 2016 | - | -$16.39 M(+12.1%) | -$56.56 M(+8.0%) |
| Dec 2015 | -$52.37 M(+175.3%) | -$14.62 M(-25.0%) | -$52.39 M(+26.7%) |
| Sep 2015 | - | -$19.50 M(+221.7%) | -$41.35 M(+57.1%) |
| Jun 2015 | - | -$6.06 M(-50.4%) | -$26.32 M(+5.9%) |
| Mar 2015 | - | -$12.22 M(+241.8%) | -$24.84 M(+30.6%) |
| Dec 2014 | -$19.02 M(-46.0%) | -$3.58 M(-19.9%) | -$19.02 M(-23.2%) |
| Sep 2014 | - | -$4.46 M(-2.6%) | -$24.77 M(-10.4%) |
| Jun 2014 | - | -$4.59 M(-28.3%) | -$27.64 M(-16.8%) |
| Mar 2014 | - | -$6.40 M(-31.4%) | -$33.24 M(-5.6%) |
| Dec 2013 | -$35.22 M(+30.7%) | -$9.32 M(+27.1%) | -$35.22 M(+3.3%) |
| Sep 2013 | - | -$7.33 M(-28.0%) | -$34.11 M(+4.9%) |
| Jun 2013 | - | -$10.18 M(+21.5%) | -$32.52 M(+13.0%) |
| Mar 2013 | - | -$8.38 M(+2.0%) | -$28.78 M(+6.8%) |
| Dec 2012 | -$26.94 M(-25.7%) | -$8.21 M(+42.8%) | -$26.94 M(+6.9%) |
| Sep 2012 | - | -$5.75 M(-10.6%) | -$25.20 M(+9.7%) |
| Jun 2012 | - | -$6.44 M(-1.5%) | -$22.98 M(+13.3%) |
| Mar 2012 | - | -$6.54 M(+1.0%) | -$20.28 M(-44.1%) |
| Dec 2011 | -$36.26 M(+275.2%) | -$6.47 M(+83.3%) | -$36.29 M(+11.2%) |
| Sep 2011 | - | -$3.53 M(-5.5%) | -$32.63 M(+4.6%) |
| Jun 2011 | - | -$3.74 M(-83.4%) | -$31.18 M(+13.6%) |
| Mar 2011 | - | -$22.55 M(+700.0%) | -$27.45 M(+460.1%) |
| Dec 2010 | -$9.66 M | -$2.82 M(+35.4%) | -$4.90 M(+135.4%) |
| Sep 2010 | - | -$2.08 M | -$2.08 M |
FAQ
- What is Fortress Biotech annual EBITDA?
- What is the all time high annual EBITDA for Fortress Biotech?
- What is Fortress Biotech annual EBITDA year-on-year change?
- What is Fortress Biotech quarterly EBITDA?
- What is the all time high quarterly EBITDA for Fortress Biotech?
- What is Fortress Biotech quarterly EBITDA year-on-year change?
- What is Fortress Biotech TTM EBITDA?
- What is the all time high TTM EBITDA for Fortress Biotech?
- What is Fortress Biotech TTM EBITDA year-on-year change?
What is Fortress Biotech annual EBITDA?
The current annual EBITDA of FBIO is -$133.64 M
What is the all time high annual EBITDA for Fortress Biotech?
Fortress Biotech all-time high annual EBITDA is -$9.66 M
What is Fortress Biotech annual EBITDA year-on-year change?
Over the past year, FBIO annual EBITDA has changed by +$60.05 M (+31.00%)
What is Fortress Biotech quarterly EBITDA?
The current quarterly EBITDA of FBIO is -$21.07 M
What is the all time high quarterly EBITDA for Fortress Biotech?
Fortress Biotech all-time high quarterly EBITDA is -$2.08 M
What is Fortress Biotech quarterly EBITDA year-on-year change?
Over the past year, FBIO quarterly EBITDA has changed by -$15.11 M (-253.81%)
What is Fortress Biotech TTM EBITDA?
The current TTM EBITDA of FBIO is -$108.43 M
What is the all time high TTM EBITDA for Fortress Biotech?
Fortress Biotech all-time high TTM EBITDA is -$2.08 M
What is Fortress Biotech TTM EBITDA year-on-year change?
Over the past year, FBIO TTM EBITDA has changed by +$51.22 M (+32.08%)